#India #Hyderabad #ProPharma #Odyssey Investment Partners

ProPharma Expands Operations with New Office in Hyderabad

On December 11, 2025, ProPharma announced the grand opening of its new office located in Hyderabad, India, which took place on November 17, 2025. As the leading provider of regulatory, clinical, and compliance services in the life sciences industry, ProPharma continues to solidify its global presence.

The new office is situated in Mindspace, strategically placed in Hyderabad’s vibrant technology corridor known as HITEC City or Madhapur. This location places ProPharma among the elite Global Capability Centers (GCCs) of the pharmaceutical sector. Mindspace has gained recognition as the first commercial business park in Hyderabad to earn a Gold rating from the Indian Green Building Council (IGBC), underlining its commitment to sustainable and environmentally friendly practices.

The prominent display of the ProPharma logo atop the building signifies the firm's escalating footprint in India, enhancing brand visibility as it expands its operations. This strategic growth initiative allows the company to onboard more team members across various service lines while providing a collaborative work environment aimed at fostering innovation and teamwork. Over 70 employees were actively involved in the inaugural celebration, highlighting the collective enthusiasm surrounding this milestone.

Jason DeGoes, President of ProPharma, remarked, "This milestone represents an important step forward in ProPharma's global expansion. Our new Hyderabad office strengthens our ability to deliver high-quality, integrated solutions for our clients around the world and reflects our commitment to building an exceptional environment for our teams."

In discussing the office's design and function, Pavan Hemadri, Director of Business Operations at ProPharma, expressed his pride in creating a world-class workspace that encourages creativity, efficiency, and collaboration. He stated, "This move enhances our ability to attract top local talent and better serve our clients across regulatory, clinical, and compliance domains."

The state-of-the-art facility is designed with open and collaborative workspaces that echo ProPharma's global culture of innovation and operational excellence. This expansion is particularly vital for ProPharma's long-term investment in India, emphasizing its strategic vision of supporting worldwide operations from key regional hubs.

For over 25 years, ProPharma has been dedicated to improving patient health and wellness by offering expertise and advice that empowers organizations in biopharmaceuticals, medical devices, and healthcare. The firm supports clients in advancing their scientific breakthroughs and bringing new therapies to market. ProPharma’s comprehensive suite of customizable consulting solutions includes areas such as regulatory sciences, clinical research, quality compliance, pharmacovigilance, medical information, and digital transformation. By enhancing these services, ProPharma aids partners in mitigating risks and expediting their high-profile drug and device programs.

About ProPharma

ProPharma has established itself as a trusted advisor in the life sciences arena, supporting clients in navigating complex regulatory environments while ensuring compliance and fostering innovation. Its extensive experience has made it a vital resource for pharmaceutical, biotech, and medical device companies globally. To learn more about ProPharma, visit propharmagroup.com.

About Odyssey Investment Partners

Odyssey Investment Partners, a prominent private equity investment firm, has over 25 years of experience in transforming middle-market companies into more efficient and diversified businesses that demonstrate strong growth. The firm focuses on investing in industries poised for long-term positive trajectories and favorable trends. For additional details about Odyssey, please visit odysseyinvestment.com.